Brief: Dicot Pharma Q4 Net Sales Of 0.0 Msek
18/02/2026 07:09
Feb 18 (Reuters) - Dicot Pharma AB DICOT.ST: Q4 NET SALES OF 0.0 MSEK Q4 PROFIT AFTER FINANCIAL ITEMS AMOUNTED TO SEK -16.8 (-20.8) MILLION Q4 EPS OF -0.01 SEK Source text: ID:nMFN5M5j5B Further company coverage: DICOT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA